Ikhlas S. Ahmed, Ph.D.
Affiliations: | 2010 | University of Kentucky, Lexington, KY |
Area:
Oncology, Molecular BiologyGoogle:
"Ikhlas Ahmed"Parents
Sign in to add mentorRolf Craven | grad student | 2010 | University of Kentucky | |
(Novel aspects of PGRMC1: Tumorigenesis promotion, EGFR stabilization and P450 activation in breast and lung cancer.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Al Balushi N, Hassan SI, Abdullah N, et al. (2022) Addition of Gallic Acid Overcomes Resistance to Cisplatin in Ovarian Cancer Cell Lines. Asian Pacific Journal of Cancer Prevention : Apjcp. 23: 2661-2669 |
Al-Bahlani S, Burney IA, Al-Dhahli B, et al. (2020) Boswellic acid sensitizes gastric cancer cells to Cisplatin-induced apoptosis via p53-mediated pathway. Bmc Pharmacology & Toxicology. 21: 64 |
Ahmed IS, Chamberlain C, Craven RJ. (2012) S2R(Pgrmc1): the cytochrome-related sigma-2 receptor that regulates lipid and drug metabolism and hormone signaling. Expert Opinion On Drug Metabolism & Toxicology. 8: 361-70 |
Mir SU, Ahmed IS, Arnold S, et al. (2012) Elevated progesterone receptor membrane component 1/sigma-2 receptor levels in lung tumors and plasma from lung cancer patients. International Journal of Cancer. 131: E1-9 |
Ahmed IS, Rohe HJ, Twist KE, et al. (2010) Pgrmc1 (progesterone receptor membrane component 1) associates with epidermal growth factor receptor and regulates erlotinib sensitivity. The Journal of Biological Chemistry. 285: 24775-82 |
Ahmed IS, Rohe HJ, Twist KE, et al. (2010) Progesterone receptor membrane component 1 (Pgrmc1): A heme-1 domain protein that promotes tumorigenesis and is inhibited by a small molecule Journal of Pharmacology and Experimental Therapeutics. 333: 564-573 |
Rohe HJ, Ahmed IS, Twist KE, et al. (2009) PGRMC1 (progesterone receptor membrane component 1): a targetable protein with multiple functions in steroid signaling, P450 activation and drug binding. Pharmacology & Therapeutics. 121: 14-9 |
Ranney MK, Ahmed IS, Potts KR, et al. (2007) Multiple pathways regulating the anti-apoptotic protein clusterin in breast cancer. Biochimica Et Biophysica Acta. 1772: 1103-11 |
Alderton F, Darroch P, Sambi B, et al. (2001) G-protein-coupled Receptor Stimulation of the p42/p44 Mitogen-activated Protein Kinase Pathway Is Attenuated by Lipid Phosphate Phosphatases 1, 1a, and 2 in Human Embryonic Kidney 293 Cells Journal of Biological Chemistry. 276: 13452-13460 |